» Articles » PMID: 12184549

Sexually Transmitted Diseases Treatment Guidelines 2002. Centers for Disease Control and Prevention

Overview
Journal MMWR Recomm Rep
Specialty Public Health
Date 2002 Aug 20
PMID 12184549
Citations 159
Affiliations
Soon will be listed here.
Abstract

These guidelines for the treatment of patients who have sexually transmitted diseases (STDs) were developed by the Centers for Disease Control and Prevention (CDC) after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on September 26-28, 2000. The information in this report updates the 1998 Guidelines for Treatment of Sexually Transmitted Diseases (MMWR 1998;47 [No. RR-1]). Included in these updated guidelines are new alternative regimens for scabies, bacterial vaginosis, early syphilis, and granuloma inguinale; an expanded section on the diagnosis of genital herpes (including type-specific serologic tests); new recommendations for treatment of recurrent genital herpes among persons infected with human immunodeficiency virus (HIV); a revised approach to the management of victims of sexual assault; expanded regimens for the treatment of urethral meatal warts; and inclusion of hepatitis C as a sexually transmitted infection. In addition, these guidelines emphasize education and counseling for persons infected with human papillomavirus, clarify the diagnostic evaluation of congenital syphilis, and present information regarding the emergence of quinolone-resistant Neisseria gonorrhoeae and implications for treatment. Recommendations also are provided for vaccine-preventable STDs, including hepatitis A and hepatitis B.

Citing Articles

British Association of Sexual Health and HIV UK national guideline for the management of anogenital herpes, 2024.

Patel R, Green J, Moran B, Clarke E, Seneviratne K, Evans C Int J STD AIDS. 2024; 36(2):90-105.

PMID: 39374063 PMC: 11773994. DOI: 10.1177/09564624241282396.


A Case of Neonatal Chlamydial Conjunctivitis: Illustrating the Typical Aspects of Presentation and the Importance of Empiric Treatment and a Multidisciplinary Approach.

Nwokeji I, Ding K, Ketner S Cureus. 2024; 16(7):e64463.

PMID: 39135809 PMC: 11318493. DOI: 10.7759/cureus.64463.


Prevalence of Cefixime-Resistant Neisseria gonorrhoeae in Melbourne, Australia, 2021-2022.

Chow E, Stevens K, De Petra V, Chen M, Bradshaw C, Sherry N J Infect Dis. 2024; 230(5):e1121-e1125.

PMID: 38877763 PMC: 11565866. DOI: 10.1093/infdis/jiae313.


Differential Screening for Nonviral Sexually Transmitted Infections by Type of Vaginitis Testing.

Pinto C, Jung M, Wimmer M, Goldblatt C, Sweeney N, Broache M Sex Transm Dis. 2023; 50(8):531-535.

PMID: 37074317 PMC: 10348635. DOI: 10.1097/OLQ.0000000000001820.


Bioactive Compounds as Potential Agents for Sexually Transmitted Diseases Management: A Review to Explore Molecular Mechanisms of Action.

Sharifi-Rad J, Quispe C, Rahavian A, Carneiro J, Rocha J, Borges Leal A Front Pharmacol. 2021; 12:674682.

PMID: 34504422 PMC: 8421529. DOI: 10.3389/fphar.2021.674682.